225 related articles for article (PubMed ID: 16753260)
1. Lack of cyclic AMP-specific phosphodiesterase 4 activation during naloxone-precipitated morphine withdrawal in rats.
Kimura M; Tokumura M; Itoh T; Inoue O; Abe K
Neurosci Lett; 2006 Aug; 404(1-2):107-11. PubMed ID: 16753260
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 4 inhibitors, rolipram and diazepam block the adaptive changes observed during morphine withdrawal in the heart.
González-Cuello A; Sánchez L; Hernández J; Teresa Castells M; Victoria Milanés M; Laorden ML
Eur J Pharmacol; 2007 Sep; 570(1-3):1-9. PubMed ID: 17601555
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
4. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus.
Núñez C; González-Cuello A; Sánchez L; Vargas ML; Milanés MV; Laorden ML
Eur J Pharmacol; 2009 Oct; 620(1-3):1-8. PubMed ID: 19683523
[TBL] [Abstract][Full Text] [Related]
5. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
[TBL] [Abstract][Full Text] [Related]
6. Behaviour of [11C]R(-)- and [11C]S(+)-rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4.
Parker CA; Matthews JC; Gunn RN; Martarello L; Cunningham VJ; Dommett D; Knibb ST; Bender D; Jakobsen S; Brown J; Gee AD
Synapse; 2005 Mar; 55(4):270-9. PubMed ID: 15668983
[TBL] [Abstract][Full Text] [Related]
7. Effect of narcotic dependence and withdrawal on striatal dopamine-sensitive adenylate cyclase and synaptosomal cyclic AMP metabolism.
Merali Z; Tsang B; Singhal RL; Hrdina PD
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):29-37. PubMed ID: 180579
[TBL] [Abstract][Full Text] [Related]
8. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
9. Opiates, cyclic nucleotides, and xanthines.
Collier HO; Francis DL; Roy AC
Adv Biochem Psychopharmacol; 1976; 15():337-45. PubMed ID: 192053
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
Almela P; Victoria Milanés M; Luisa Laorden M
Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
[TBL] [Abstract][Full Text] [Related]
11. Alterations in protein kinase A and different protein kinase C isoforms in the heart during morphine withdrawal.
Cerezo M; Milanés MV; Laorden ML
Eur J Pharmacol; 2005 Oct; 522(1-3):9-19. PubMed ID: 16202991
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with midazolam suppresses morphine withdrawal response in mice and rats.
Cao JL; Ding HL; Zhang LC; Duan SM; Zeng YM
Acta Pharmacol Sin; 2002 Aug; 23(8):685-90. PubMed ID: 12147189
[TBL] [Abstract][Full Text] [Related]
13. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
Kimes AS; London ED
J Pharmacol Exp Ther; 1989 Feb; 248(2):538-45. PubMed ID: 2918470
[TBL] [Abstract][Full Text] [Related]
14. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
Zhao Y; Zhang HT; O'Donnell JM
J Pharmacol Exp Ther; 2003 May; 305(2):565-72. PubMed ID: 12704225
[TBL] [Abstract][Full Text] [Related]
16. Naloxone increases vascular responsiveness in chronic morphine treated rats and facilitates intracellular signaling in cultured vascular cells.
Wang Y; Xu JG; Yu YQ; Wang HY; Jiang B; Li XY
Acta Pharmacol Sin; 2001 Oct; 22(10):881-6. PubMed ID: 11749769
[TBL] [Abstract][Full Text] [Related]
17. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
18. Changes in ribonuclease in the central nervous system of mice during morphine dependence development, withdrawal and naloxone administration.
Mohanakumar KP; Sood PP
Clin Physiol Biochem; 1986; 4(2):159-63. PubMed ID: 2421960
[TBL] [Abstract][Full Text] [Related]
19. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
[TBL] [Abstract][Full Text] [Related]
20. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
Mamiya T; Matsumura T; Ukai M
Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
